Document is current
Any future updates will be listed below
-
Authors
Greco, Lucia Catherine https://orcid.org/0000-0003-3659-4034
Lizio, Andrea https://orcid.org/0000-0002-8875-9665
Casiraghi, Jacopo
Sansone, Valeria Ada https://orcid.org/0000-0002-1354-3800
Tremolizzo, Lucio https://orcid.org/0000-0003-0473-6560
Riva, Nilo https://orcid.org/0000-0002-0513-9517
Solca, Federica https://orcid.org/0000-0002-3274-3963
Torre, Silvia
Ticozzi, Nicola https://orcid.org/0000-0001-5963-7426
Filippi, Massimo https://orcid.org/0000-0002-5485-0479
Silani, Vincenzo https://orcid.org/0000-0002-7698-3854
Poletti, Barbara https://orcid.org/0000-0003-4398-2051
Lunetta, Christian https://orcid.org/0000-0002-4788-1875
- License Information
-
More Information
Article History
Received: 3 May 2021
Revised: 5 August 2021
Accepted: 6 August 2021
First Online: 19 August 2021
Declarations
:
: CL received compensation for occasional scientific consulting from Neuraltus, Cytokinetics, Mitsubishi Tanabe Pharma Europe and Italfarmaco and has received funds from ARISLA and Italian Ministry of Health, AL received compensation for occasional scientific consulting from Italfarmaco, VAS participates in Advisory Boards or Teaching activities for Biogen, Roche, Avexis, PTC, Santhera, and Sarepta, Dyne. Other authors declared no disclosures.
: The study design was approved by the institutional ethical committees of Milano Area 3 and all the subjects involved signed the informed consent in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: All the subjects involved in the study participated willingly.
: All the subjects involved signed the informed consent for publication data.
